Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02537444
Brief Title: Acalabrutinib (ACP-196) Alone and in Combination With Pembrolizumab in Ovarian Cancer (KEYNOTE191)

First Submitted : August 28, 2015
First Submitted that Met QC Criteria : August 28, 2015
First Posted : September 1, 2015 (Estimate)

Results First Submitted : August 5, 2019
Results First Submitted that Met QC Criteria : August 22, 2019
Results First Posted : September 12, 2019

Last Update Submitted that Met QC Criteria : August 22, 2019
Last Update Posted : September 12, 2019